Liquid Biopsy for Precision Oncology Summit West Coast leaderboard
  • Friday, November 20, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

SmartLab Exchange Europe 2027 Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Page 926

Sunesis Pharmaceuticals Announces Withdrawal of European MAA for Vosaroxin as a Treatment for…

May 2, 2017
Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) announced today that the Company will withdraw its European Marketing Authorization Application (MAA) for vosaroxin as a treatment for…
Read More...

NEUROTROPE Announces Positive Top-Line Results From Phase 2 Study of Bryostatin-1 for Moderate to…

May 2, 2017
Neurotrope, Inc. announced positive top-line results from its Phase 2 study (-202 Study) of Bryostatin-1 in patients with moderate to severe Alzheimer's disease (AD), a population not…
Read More...

GSK invests $139 million to expand production capacity for BENLYSTA (belimumab) in Rockville, MD

May 2, 2017
GSK announced $139 million of new investment in its biopharmaceutical manufacturing site in Rockville, MD to support growing demand for BENLYSTA® (belimumab) for adult patients with…
Read More...

Shire and Parion Sciences Enter into a Collaborative License Agreement to Advance P-321 for…

May 2, 2017
Shire plc and Parion Sciences, Inc. announced they have entered into an agreement granting Shire exclusive worldwide rights to develop and commercialize P-321. Shire will lead…
Read More...

Agreement to buy F-Star Alpha between Bristol-Myers Squibb and F-star Alpha terminated

May 1, 2017
Agreement to buy F-Star Alpha and its lone asset, FS102 between Bristol-Myers Squibb and F-star Alpha has been terminated. Bristol-Myers Squibb and F-star Alpha, entered into an…
Read More...

Sorrento Therapeutics successfully completes acquisition of Virttu Biologics

May 1, 2017
Sorrento Therapeutics announced that it has successfully completed the transaction for acquisition of Virttu Biologics. In consideration for the acquisition, Virttu equity holders…
Read More...

Dr. Wilson appointed TAPIMMUNE President after Dr. Bonfiglio’s resignation

May 1, 2017
TAPIMMUNE announced that Dr. Wilson has been appointed President after Dr.John Bonfiglio’s resigned as Chief Operating Officer, President and director of TapImmune Inc. to pursue other…
Read More...

FDA approves Rydapt in combination with Chemotherapy for treatment of AML

May 1, 2017
The U.S. FDA approved Rydapt (midostaurin) in combination with Chemotherapy for the treatment of adult patients with newly diagnosed AML (acute myeloid leukemia) who have a specific…
Read More...

MedMira receives CE Marks on its syphilis/HIV rapid test

May 1, 2017
MedMira has received CE mark on its syphilis/HIV rapid test, Multiplo TP/HIV, this approval allows company to market and distribute the multiplex rapid test throughout the European…
Read More...

Allergan completes acquisition of ZELTIQ Aesthetic

May 1, 2017
Allergan announced that it has completed the acquisition of ZELTIQ Aesthetics for $2.4 billion cash. ZELTIQ stockholders approved the transaction during the meeting held on April 27,…
Read More...
Previous 1 … 924 925 926 927 928 … 966 Next
Oligonucleotide-based Therapeutics Summit
LEAP HR: Life Sciences Europe
3rd Annual TRP Target Selection & Drug Design Summit
2nd Structure-Based Drug Design Summit San Diego
Liquid Biopsy for Precision Oncology Summit West Coast
2nd Non-Opioid Pain Therapeutics Summit
Muscular Disorders Drug Development Summit
Amylin-Based Therapeutics Summit
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Antigen-Specific Immune Tolerance Summit
7th Operationalize Expanded Access Programs Summit
Viral Vector Process Development & Manufacturing Summit
SmartLab Exchange Europe 2027
8th RNAi-Based Therapeutics Summit
17th World ADC London
PFS & Injectable Drug Devices Europe
Ophthalmic Drug Delivery Summit
Obesity & Weight Loss Drug Development Summit West
ADC Payload Summit 2026
10th Antifibrotic Drug Development Summit 2026
Biomarker Operations & Biospecimen Management
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • OBI Pharma Signs $2 Billion ADC Deal with Novartis
  • Erasca and Bristol Myers Squibb Partner on Pancreatic Cancer Treatment
  • GSK Wins FDA Approval for Nelkarmi in Advanced Lung Cancer
  • OXB Partners with Aura Biosciences for Phase 3 Cancer Drug Development
  • Skylark Bio Advances Hearing Loss Gene Therapy to Younger Children

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Cell Therapy Safety in Autoimmune Disease

7th Operationalize: Expanded Access Programs Summit East…

As AI and ICH M15 Transform Drug Development, Industry…

Industry Leaders Explore the Future of RNA Therapeutics…

Direct RNA Binding Emerges as a Powerful Approach for…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.